000 | 01036 a2200289 4500 | ||
---|---|---|---|
005 | 20250518035518.0 | ||
264 | 0 | _c20200512 | |
008 | 202005s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.18.02369 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aQin, Shukui | |
245 | 0 | 0 |
_aReply to C. Kersten et al and D.A. Parikh et al. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c06 2019 |
||
300 |
_a1592-1593 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 | _aFluorouracil |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeucovorin |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 | _aRectal Neoplasms |
700 | 1 | _aLiu, Tianshu | |
700 | 1 | _aLi, Jin | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 37 _gno. 18 _gp. 1592-1593 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.18.02369 _zAvailable from publisher's website |
999 |
_c29648905 _d29648905 |